Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure-Anne Van Bellinghen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|June 7, 2014
The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort modelLaure-Anne Van Bellinghen, Genevieve Meier, Ilse Van Vlaenderen
MDM Policy & Practice|August 7, 2019
Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to GhanaChristophe Sauboin, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, et al.
BMC Infectious Diseases|January 24, 2013
An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static modelsIlse Van Vlaenderen, Laure-Anne Van Bellinghen, Genevieve Meier, et al.
MDM Policy & Practice|December 20, 2019
Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 CountriesChristophe Sauboin, Laure-Anne Van Bellinghen, Nicolas Van De Velde, et al.
Malaria Journal|December 26, 2015
Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling studyChristophe J Sauboin, Laure-Anne Van Bellinghen, Nicolas Van De Velde, et al.
Value in Health Regional Issues|April 13, 2021
Constrained Optimization for Pneumococcal Vaccination in BrazilJan Olbrecht, Jorge A Gomez, Laure-Anne Van Bellinghen, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 22, 2018
Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model typesLaure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, et al.
Human Vaccines & Immunotherapeutics|May 18, 2018
Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?Laure-Anne Van Bellinghen, Alex Dimitroff, Michael Haberl, et al.
Infectious Diseases and Therapy|March 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United StatesDaniel Molnar, Elizabeth M La, Frederik Verelst, et al.
Applied Health Economics and Health Policy|November 23, 2019
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration ProjectBaudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|June 7, 2014
The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort modelLaure-Anne Van Bellinghen, Genevieve Meier, Ilse Van Vlaenderen
MDM Policy & Practice|August 7, 2019
Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to GhanaChristophe Sauboin, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, et al.
BMC Infectious Diseases|January 24, 2013
An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static modelsIlse Van Vlaenderen, Laure-Anne Van Bellinghen, Genevieve Meier, et al.
MDM Policy & Practice|December 20, 2019
Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 CountriesChristophe Sauboin, Laure-Anne Van Bellinghen, Nicolas Van De Velde, et al.
Malaria Journal|December 26, 2015
Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling studyChristophe J Sauboin, Laure-Anne Van Bellinghen, Nicolas Van De Velde, et al.
Value in Health Regional Issues|April 13, 2021
Constrained Optimization for Pneumococcal Vaccination in BrazilJan Olbrecht, Jorge A Gomez, Laure-Anne Van Bellinghen, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 22, 2018
Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model typesLaure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, et al.
Human Vaccines & Immunotherapeutics|May 18, 2018
Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?Laure-Anne Van Bellinghen, Alex Dimitroff, Michael Haberl, et al.
Infectious Diseases and Therapy|March 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United StatesDaniel Molnar, Elizabeth M La, Frederik Verelst, et al.
Applied Health Economics and Health Policy|November 23, 2019
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration ProjectBaudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, et al.
Pageof 2